[Results of immunosuppressive treatment of visceral lupus erythematosus].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001379:Azathioprine / Q000627:therapeutic use*; D004342:Drug Hypersensitivity; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use*; D008875:Middle Aged; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced
D007166:Immunosuppressive Agents; D009588:Nitrogen Mustard Compounds; D015122:Mercaptopurine; D001379:Azathioprine
Wyniki immunosupresyjnego leczenia tocznia trzewnego.